baber/WOPTO huggingface dataset:
Patent CA-2947597-A1 (CA)
Title: Boitier refrigere equipe d'un systeme d'ecoulement d'air induit
Inventor: BATES ROY
IPC: F25D23/00
Filed: 2016-11-04
Abstract: Il est décrit des systèmes et méthodes portant sur une boîte climatisée. La boîte climatisée comprend un boîtier définissant un espace climatisé et une ouverture par laquelle un utilisateur peut accéder à lespace climatisé. La boîte comprend également un élément de refroidissement en communication thermique avec lespace climatisé. Finalement, la boîte climatisée comprend un plénum modulaire couplé au boîtier et disposé à larrière de lélément de refroidissement par rapport à louverture. Le plénum modulaire en question comprend les éléments suivants : au moins un ventilateur couplé de façon amovible au plénum modulaire, lesquels ventilateur fait circuler lair dans lélément de refroidissement; au moins un connecteur électrique couplé au plénum modulaire et disposé à proximité de chacun des ventilateurs en vue de lui fournir une alimentation électrique.
Patent CA-2948552-A1 (CA)
Inventor: HOLTAN SYNNOVE
IPC: D21B1/36
Filed: 2015-05-29
Abstract: The present invention relates to microfibrillated cellulose ("MFC"), in particular to microfibrillated cellulose, which is morphologically different from conventional MFC known in the art and/or which provides improved water retention properties and/or improved rheological properties, in particular increased zero shear viscosity, ?0, (also known as: "viscosity at rest", i.e. viscosity in the absence of shear forces), in solution, in particular in polyethylene glycol (PEG) as solvent, vis-a-vis conventional MFC as known in the art.
Patent CA-2949271-A1 (CA)
Inventor: BUHLER JARED PETER
IPC: F01D5/18
Filed: 2016-11-22
Abstract: An airfoil for a gas turbine engine can have an exterior wall and an interior wall, with each wall having a thickness. The walls can intersect to define a corner at the intersection. A cooling passage can be defined by the walls at or near the corner to provide fluid communication between the interior and exterior of the airfoil. A film hole can be disposed in the walls and can have a length and diameter to define a ratio of length to diameter, L/D. An arcuate fillet can be located in the corner to define an effective radius for the fillet. The effective radius can be at least 1.5 times larger than the thicknesses of the walls to provide for an increased length to diameter ratio for the film hole.
Patent CA-2950570-A1 (CA)
Title: Breast cancer detection kit or device, and detection method
Inventor: KONDOU SATOSHI
IPC: C12N15/09
Filed: 2015-06-12
Abstract: The present invention provides a kit or a device for the detection of breast cancer, comprising nucleic acid(s) capable of specifically binding to a miRNA, including the breast cancer marker miR-7114-5p, in a sample of a subject. The present invention also provides a method for detecting breast cancer, comprising measuring the miRNA including miR-7114-5p in vitro.
Patent CA-2951186-A1 (CA)
Inventor: GUEDAT PHILIPPE
IPC: C07D295/088
Filed: 2015-07-02
Abstract: The present invention relates to a compound of formula (I), or a tautomer and/or a pharmaceutically acceptable salt thereof Formula (I), and its uses to treat a disorder associated with protein misfolding stress and in particular with an accumulation of misfolded proteins.
Patent CA-2952834-A1 (CA)
Inventor: LIN RONG-HWA
IPC: A61K39/395
Filed: 2015-06-18
Abstract: The present disclosure provides compounds with a hydrophilic self-immolative linker, which is cleavable under appropriate conditions and incorporates a hydrophilic group to provide better solubility of the compound. The compounds of the present disclosure comprise a drug moiety, a targeting moiety capable of targeting a selected cell population, and a linker which contains an acyl unit, an optional spacer unit for providing distance between the drug moiety and the targeting moiety, a peptide linker which can be cleaved under appropriate conditions, a hydrophilic self-immolative linker, and an optional second self-immolative spacer or cyclization self-elimination linker. In some aspects of the present disclosure, the targeting moiety is an anti-HER2 antibody. The present disclosures further provide compositions and methods for treating cancers.
Patent CA-2955713-A1 (CA)
Inventor: CAO GUOHUA
IPC: B66B9/04
Filed: 2015-12-22
Abstract: Disclosed are a multi-cylinder synchronous energy-saving and efficient hydraulic lift system and a method of the system, which are applicable to lift systems such as hydraulic lifts and construction elevator platforms, etc. The system comprises an oil make-up circuit, a volumetric speed control and energy recovery circuit, a manual lifting circuit, a synchronous locking circuit, hydraulic cylinders, and an inclination sensor, wherein, the oil make-up circuit is configured to make up inadequate hydraulic oil in a closed loop system incurred by regulation with the synchronous locking circuit and system leakage, and reduce oil temperature rise; the volumetric speed control and energy recovery circuit is configured to provide power to the system, regulate the speed, and recover energy; the manual lifting circuit is configured to lift and lower the platform manually when the system has faults; the synchronous locking circuit is configured to control the plurality of hydraulic cylinders to ascend/descend synchronously and lock up the hydraulic cylinders when the platform is in a still state; the inclination sensor detects the position of the platform and feeds back the position information to a control center in real time, so as to realize closed-loop control. The system is efficient and energy-saving, and realizes energy recovery and accurate synchronization among the hydraulic cylinders, and the lifting platform is highly tolerant to unbalanced load, operates stably, and has high reliability.
Patent CA-2956184-A1 (CA)
Inventor: BREMOND MELANIE
IPC: C12N9/02
Filed: 2015-07-23
Abstract: The présent invention relates to a recombinant yeast having a reduced pyruvate dccarboxylase activity, in thc génome of which has been inserted: - one or more nucleic acids encoding an acetolactate synthasc or ALS, - one or more nucleic acids encoding an acetolactate decarboxylasc or ALD, and - one or more copies of a nucleic acids encoding a NADH oxidase or NOXE.
Patent CA-2957416-A1 (CA)
Inventor: VAN NGA K
IPC: A61F11/00
Filed: 2015-08-07
Abstract: An instrument (300) comprises a shaft assembly (315), a handpiece body (302), and a drive assembly. The shaft assembly comprises a plurality of coaxially arranged shafts and a tympanostomy tube. The shaft assembly further includes a flexible section (324). The shaft assembly extends distally from the handpiece body. The drive assembly is operable to drive the shafts of the shaft assembly in a predetermined sequence to deploy the tympanostomy tube. One or more of the shafts are configured to translate along the flexible section of the shaft assembly as a part of the predetermined sequence to deploy the tympanostomy tube.
Patent CA-2959692-A1 (CA)
Title: Internally heated engine inlet screen for aircraft engines
Inventor: GRISSINO ALAN SCOTT
IPC: B64D15/02
Filed: 2017-03-02
Abstract: An apparatus for providing foreign object debris protection and anti-icing capabilities to an air intake of an aircraft engine. The apparatus includes a frame having at least a portion configured to conduct fluids. A tube is positioned such that different portions of the frame are fluidly connected. There is a discharge outlet defined within the frame that is configured to discharge fluids from the frame into the air intake. An inlet is defined within the frame and is fluidly connected to a compressor section of the aircraft engine. In this manner, air from the compressor section of the aircraft engine can flow through the inlet, through the tube, and through the discharge outlet, to return to the compressor section of the aircraft engine.
Patent CA-2960455-A1 (CA)
Inventor: VISHWAKARMA RAM
IPC: A61P31/04
Filed: 2015-10-21
Abstract: The present invention relates to s pharmaceutical composition for the treatment of multi-drug resistant infections comprising benzopyrano[3,4-b][1]benzopyran-12(6H)-one class of compound boeravinone B of formula 1 in combination with antimicrobial agent. The present invention particularly relates to the potentiation of the bio-efficacy of anti-infective drugs, when used in combination with boeravinone B. The present invention further relates to the use of boeravinone B to overcome the resistance or multi-drug resistance developed by bacteria against quinolone, mupirocin and macrolide class of anti-bacterial agents via inhibition of bacterial efflux pumps. In addition, the invention relates to methods of using compounds for treating or preventing drug-resistant bacterial diseases.
Patent CA-2965533-A1 (CA)
Title: Automated exchange of healthcare information for fulfillment of medication doses
Inventor: PADMANI BHAVESH S
IPC: G16H10/60
Filed: 2015-10-26
Abstract: Automated healthcare information exchange. The healthcare information may comprise one or more dose orders corresponding to dose medications to be administered to a patient. The healthcare information may be received (e.g., from an EMR system such as a hospital information system (HIS) or the like) in the form of a healthcare information data stream. The information may then be standardized in to a standardized intermediate form. For instance, data may be parsed from the data stream and used to populate a staging table. In turn, data from the staging table may be transformed into an input format specific to a given dose fulfillment client to which the dose order is provided for fulfillment of the dose. Additionally, exception processing. logistical processing, and management functionality may be applied to the dose orders.
Patent CA-2967017-A1 (CA)
Title: Microneedle arrays for cancer therapy applications
Inventor: FALO LOUIS D JR
IPC: A61M37/00
Filed: 2015-11-06
Abstract: A method of forming a microneedle array can include forming a microneedle array having one or more chemotherapeutic agents. The microneedle array can include a base portion and plurality of microneedles extending from the base portion, and the one or more chemotherapeutic agents can be present in a higher concentration in the plurality of microneedles than in the base portion.
Patent CA-2967246-A1 (CA)
Inventor: KATO SHINJI
IPC: F16J15/3204
Filed: 2015-11-04
Abstract: Provided is a seal member capable of satisfactorily scraping off foreign substances and preventing problems caused by the inclusion of foreign substances. A dust seal (39) as a seal member is provided with a dust seal body (36) and a lip member (38). The dust seal body (36) has elasticity and is held at an opening (25) of an outer tube (21) in which an inner tube (23) reciprocating while protruding is inserted. The lip member (38) is harder than the dust seal body (36) and is mounted to the front end of the dust seal body (36). The front end of the lip member (38) is in sliding contact with the outer peripheral surface of the inner tube (23).
Patent CA-2967377-A1 (CA)
Title: Diagnosis and treatment of incipient diabetes
Inventor: MALO MADHU S
IPC: C12Q1/42
Filed: 2015-11-17
Abstract: A method is described for predicting incipient diabetes, metabolic disorders or the metabolic syndrome by developing a personal temporal phosphatase profile, which is generated by measuring phosphatase concentration in stool at a single time-point or multiple time-points. The phosphatase profile further can be used for diagnosing and determining prognosis of other incipient or overt diseases, such as the metabolic syndrome, coronary heart disease, nonalcoholic fatty liver disease, cancers, other chronic or acute diseases or infectious diseases. Also described is a specific dose of phosphatase for therapeutic use in incipient diabetes and other incipient or overt diseases.
Patent CA-2968222-A1 (CA)
Inventor: HARE JOSHUA M
IPC: C12Q1/02
Filed: 2015-11-13
Abstract: La présente invention concerne des matériaux et des procédés de traitement du dysfonctionnement endothélial d'un patient. L'invention concerne également des procédés de détermination de l'efficacité du traitement.
Patent CA-2968493-A1 (CA)
Inventor: KOGISO MASAKI
IPC: B82Y30/00
Filed: 2015-11-20
Abstract: [Problem] To provide: a nanocomposite capable of easily and efficiently removing and simultaneously absorbing an oily component, a heavy metal, hydrogen sulfide, and an organic compound merely by adding wastewater, without requiring a pretreatment such as oil removal, desalinization, or hydrodesulfurization, capable of easily recovering the same after absorption, and further capable of being used in the purification of wastewater in a broad pH range from acidic to slightly alkaline; a method for producing the same; an absorbent containing the nanocomposite; and a method for using the same. [Solution] A nanocomposite according to the present invention is characterized in that magnetite nanoparticles are conjugated with an organic nano-material represented by general formula (1). In general formula (1), R represents a C6-24 hydrocarbon group, R' represents an amino acid sidechain, and m represents an integer of 1-5.
Patent CA-2969598-A1 (CA)
Title: Method for evaluating mesenchymal stem cell activity, method for culturing mesenchymal stem cells, method for producing therapeutic agent for liver dysfunction, and therapeutic agent for liver dysfunction
Inventor: SAKAIDA ISAO
IPC: C12Q1/48
Filed: 2015-08-19
Abstract: The present disclosure relates to methods for: evaluating activity level of mesenchymal stem cells; and culturing mesenchymal stem cells using the evaluation method in the field of culturing mesenchymal stem cells for regenerative medicine. The method for evaluating mesenchymal stem cell activity comprises an assay step for assaying the amount of adenylate kinase 4 (AK4) in the mesenchymal stem cells; and a determination step for determining if the activity level of the mesenchymal stem cells from the assayed amount of adenylate kinase 4 is higher than a predetermined threshold.  If the assayed amount of adenylate kinase 4 is higher than the predetermined threshold, the mitochondrial activity level of the mesenchymal stem cells is low. If the assayed amount of adenylate kinase 4 is lower than the predetermined threshold, the mitochondrial activity level of the mesenchymal stem cells is high.
Patent CA-2975066-A1 (CA)
Inventor: SAWADA AKIRA
IPC: B60L15/20
Filed: 2015-01-26
Abstract: A control device for an electric vehicle uses a motor as a traveling drive source and uses the rotation braking force of the motor to decelerate the electric vehicle. The control device detects an acceleration operation amount, calculates a disturbance torque estimated value, detects or estimates, from a vehicle state, a resistance component that is not associated with a slope, and then corrects the disturbance torque estimated value in accordance with the detected or estimated resistance component. The motor is controlled according to a motor torque command value. When the acceleration operation amount is less than or equal to a predetermined value and the electric vehicle is about to stop, the motor torque command value converges to the corrected disturbance torque estimated value as a speed parameter proportional to the rotational speed of the motor decreases.
Patent CA-2980554-A1 (CA)
Inventor: HANDY PETER JAMES
IPC: H03K17/14
Filed: 2015-04-06
Abstract: A method for operating an electrical circuit for controllably delivering power from a power source to an electrical load including a switch further configured to operate in a first conducting mode and a second non-conducting mode, and a controller, the method includes ceasing delivering power from the power source to the electrical load.
Patent CA-2980810-A1 (CA)
Inventor: CASTORENA CORTES GLADYS TERESA
IPC: C09K8/582
Filed: 2017-09-28
Abstract: The present invention is related with a biotechnological process that increases the recovery and mobilization of oils present in carbonated and/or siliciclastic porous media by the action of tensoactive biomolecules from Serratia marcescens SmSA. The invention also increases the oil recovery in reservoirs. Serratia marcescens SmSA biomolecules display tensoactive and emulsifying properties that produce changes in the surface and interfacial tensions, enhanced the recovery and mobilization of oils. The Serratia marcescens SmSA tensoactive biomolecules of the present invention are stable at temperatures from 4 to 121 °C, pH from 2 to 12, pressures from atmospheric to 1,706 psi, and NaCI content from 0 to 200 g/L (from 0 to 200,000 ppm). The Serratia marcescens SmSA tensoactive biomolecules reduce the surface tension up to 26 mN/m, the interfacial tension up to 1.8 mN/m with hexadecane, with emulsifying activity up to 71 % with the same solvent and a critical micellar concentration (CMC) of 300 mg/L. The Serratia marcescens SmSA tensoactive biomolecules enhance recovery of residual oil above 10%. 27
Patent CA-2981040-A1 (CA)
Inventor: BUELL RICHARD R
IPC: G01R19/00
Filed: 2016-03-23
Abstract: L'invention concerne un circuit de détection de tension qui comprend un amplificateur (12) ayant une première entrée (16) et une sortie d'amplificateur, la première entrée étant couplée à un nud (20) comprenant une masse virtuelle, et un premier élément d'impédance (8, 30) ayant une entrée structurée pour être couplée au conducteur et une sortie couplée à la première entrée de l'amplificateur par l'intermédiaire du nud. Le premier élément d'impédance est structuré pour amener un signal de courant ayant un courant directement proportionnel à la tension sur le conducteur et une tension sensiblement à zéro volt à être fournis à la première entrée de l'amplificateur par l'intermédiaire du nud en réponse à la tension du conducteur fournie à l'entrée du premier élément d'impédance. L'amplificateur est structuré pour amener une tension de sortie qui est directement proportionnelle au courant du signal de courant à être fournie à la sortie de l'amplificateur.
Patent CA-2982482-A1 (CA)
Title: Improved thick wrought 7xxx aluminum alloys, and methods for making the same
Inventor: BOSELLI JULIEN
IPC: C22C21/00
Filed: 2016-05-09
Abstract: Improved wrought 7xxx aluminum alloy products are disclosed. The improved wrought 7xxx aluminum alloy products generally include 6.0 - 10.0 wt. % Zn, 1.4 - 2.2 wt. % Mg, 1.3 - 2.5 wt. % Cu and 0.080 - 0.250 wt. % Cr. The improved wrought 7xxx aluminum alloy products generally have a thickness of from 3.0 inches to 12 inches, and realize an improved combination of properties, such an improved combination of crack deviation resistance, strength, fracture toughness and corrosion resistance.
Patent CA-2983269-A1 (CA)
Inventor: MISRA SIDDHARTH
IPC: G01F23/28
Filed: 2016-04-29
Abstract: A method to estimate water saturation in electromagnetic measurements includes making an electromagnetic measurement and performing at least one of (a) creating an analytical forward model of the EM measurement, (b) creating a numerical finite difference forward model of the EM measurement, and (c) performing an inversion. The method also includes removing at least one petrophysically-adverse alteration of EM measurements in the frequency range from 1 Hz to 100 MHz. A petrophysically-adverse alteration is due to the presence of at least one of the following: pyrite, graphitic-precursors, magnetite, and other conductive minerals.
Patent CA-2983732-A1 (CA)
Title: Detection fongique a l'aide d'epitope de mannane
Inventor: KOZEL THOMAS R
IPC: G01N33/569
Filed: 2016-04-23
Abstract: L'invention concerne des procédés non invasifs visant à diagnostiquer des échantillons comprenant un champignon, présentant une infection ou une contamination fongique, avec des anticorps monoclonaux spécifiques pouvant détecter des molécules associées à des champignons dans l'échantillon, tel qu'un échantillon biologique ou environnemental. Ces molécules peuvent être identifiées à l'aide de divers procédés, y compris, mais pas exclusivement, des procédés basés sur un anticorps, tel qu'un dosage d'immunoabsorption par enzyme liée (ELISA), ou un dosage immunologique à flux latéral.
Patent CA-2985024-A1 (CA)
Title: Systeme automatise de couplage de la chaine cinematique d'une tete de recolte
Inventor: SARAIVA DANIEL
IPC: A01D47/00
Filed: 2016-06-08
Abstract: L'invention concerne un système de couplage de chaîne cinématique de tête de récolte (20 ; 120) comprenant une chaîne cinématique de moissonneuse (38 ; 138) montée sur un véhicule de récolte (10) et un arbre d'entraînement de tête (40) monté sur une tête de récolte amovible (18). La chaîne cinématique de moissonneuse (38 ; 138) est supportée pour la rotation au niveau d'une extrémité intérieure sur un convoyeur (16) et au niveau d'une extrémité extérieure sur le cadre d'inclinaison de la tête (24) même lorsque celle-ci est détachée. La chaîne cinématique de moissonneuse comprend une partie télescopique (48 ; 148) qui permet à un élément de couplage (97; 197) sur l'extrémité extérieure d'être introduit pour être en prise et hors de prise avec un élément de couplage (99) de l'arbre d'entraînement de tête (40). Un ensemble de support coulissant (64 ; 164) est prévu pour supporter un boîtier de palier (56 ; 156) qui maintient l'extrémité extérieure de la chaîne cinématique de moissonneuse sur le cadre d'inclinaison (24). Un actionneur (84) est conçu pour déplacer le boîtier de palier (56 ; 156) par rapport au cadre d'inclinaison (24) pour enclencher et désengager de façon sélective les éléments de couplage (97, 99 ; 197, 199).
Patent CA-2985934-A1 (CA)
Title: A wetting system for providing a wetting effect to a fabric or textile
Inventor: BROWN NICHOLAS
IPC: D06M15/03
Filed: 2016-05-17
Abstract: The invention relates to a wetting system for providing a wetting effect to a fabric or textile comprising a solution of an alkylpolyglucoside in combination with a solution of a Group 4 metal salt. The invention also relates to a process for producing a wetting or re-wetting effect on a textile or fabric comprising applying a wetting system to the fabric that comprises a solution of an alkyl polyglucoside in combination with a solution of a Group 4 metal salt and drying the fabric at a low temperature, i.e. less than 100°C.
Patent CA-2986422-A1 (CA)
Inventor: HOWSON CHRIS
IPC: A61H23/00
Filed: 2016-05-17
Abstract: A portable therapeutic apparatus is disclosed. The portable therapeutic apparatus may include a handle, a protrusion, a resistance element, and an adjustment element attached to the handle. The handle may include a first slot that houses the resistance element. The protrusion may include an indentation. The resistance element may include an elastic element.
Patent CA-2987549-A1 (CA)
Title: Procede et installation de preparation de biomasse
Inventor: VIESLET JEAN-PAUL
IPC: C12M1/00
Filed: 2016-06-10
Abstract: La présente invention concerne un procédé et une installation de préparation de biomasse lignocellulosique, notamment par extraction d'eau et éventuellement affinage granulométrique, en vue de l'utilisation ultérieure notamment dans un procédé de torréfaction, de carbonisation, de production de granules, comme des granules de combustible ou des granules d'amélioration des sols, ou la fabrication de matériaux de construction, ou encore la préparation de produits agro-alimentaires, comportant une centrifugation (100) de la biomasse suivie d'un broyage-séchage par attrition (200).